SCNX
Scienture Holdings, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.31
+0.10%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.31
From 52W high−87.94%
Volume292664.00
Market cap$12.87M
P/E (TTM)—
P/S (TTM)15.7x
Div yield—
Key dataSep 18, 2026
Open
$0.31
From 52W high
−87.94%
Volume
292664.00
Market cap
$12.87M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
P/E (TTM)
—
RSI (14)
31.3
MomentumView details →
1D Return
+0.10%
YTD Return
−37.10%
SummaryUpdated Jun 1, 2026
Scienture Holdings, Inc. (NASDAQ:SCNX) is a healthcare information technology company founded in 2014 and headquartered in Tampa, Florida. The company operates under the brand name TRxADE HEALTH and has evolved from its original focus on pharmaceutical marketplace services to become a broader healthcare IT solutions provider. Since going public in February 2014, the company has undergone significant strategic pivots and faces ongoing operational challenges while pursuing growth in the digital healthcare sector.
Similar companies
Latest newsMore news →
Scienture Holdings reported Q2 2026 financial results with approximately 510% sequential revenue growth from Q1 2026, gross margin of about 97.7%, operating loss improved about 48% year-over-year to approximately $2.7 million, and net loss narrowed about 58% year-over-year to approximately $2.8 million.37d agoScienture Holdings announced the commercial launch of REZENOPY, the highest dose FDA-approved naloxone nasal spray, and fulfillment of initial purchase orders.39d ago